Inventor · disambiguated record
Carlo Brugnara
Also filed as: BRUGNARA CARLO
22 granted patents·6 pending applications·357 citations·filing 1992–2016
96Inventor score
Files withHARVARD COLLEGE8CHILDRENS MEDICAL CENTER6BETH ISRAEL HOSPITAL ASSOC INC2NUCHEM PHARMACEUTICALS INC2BETH ISRAEL HOSPITAL1
Top patents by PatentIndex Score
28 records- 0189US5512591ATreatments for diseases characterized by neovascularizationHARVARD COLLEGE·Filed 1993·Granted Apr 30, 1996·57 cites·24 claims
- 0285US6028103ATriaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 1997·Granted Feb 22, 2000·36 cites·42 claims
- 0380US5358959AMethods for treating arteriosclerosisHARVARD COLLEGE·Filed 1993·Granted Oct 25, 1994·39 cites·21 claims
- 0475US6331564B1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseION PHARMACEUTICALS INC·Filed 1998·Granted Dec 18, 2001·43 cites·13 claims
- 0574US5889038AMethods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compoundsCHILDRENS HOSP MEDICAL CENTER·Filed 1996·Granted Mar 30, 1999·29 cites·29 claims
- 0673US6331557B1Use of divalent cations for inhibiting erythrocyte dehydration in vivoCHILDRENS MEDICAL CENTER·Filed 2000·Granted Dec 18, 2001·10 cites·52 claims
- 0770US5633274ACancer treatmentsHARVARD COLLEGE·Filed 1993·Granted May 27, 1997·34 cites·26 claims
- 0869US6495567B1Triaryl methane compounds and their use in the treatment of diarrhea and scoursBETH ISRAEL HOSPITAL·Filed 1998·Granted Dec 17, 2002·23 cites·14 claims
- 0969US5273992AMethod for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situBETH ISRAEL HOSPITAL ASSOC INC·Filed 1992·Granted Dec 28, 1993·32 cites·8 claims
- 1068US9678088B2Multiphase systems for diagnosis of sickle cell diseaseHARVARD COLLEGE·Filed 2014·Granted Jun 13, 2017·2 cites·16 claims
- 1164US6800658B2Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 2002·Granted Oct 5, 2004·3 cites·16 claims
- 1252US5643936ATreatments for diseases characterized by neovascularizationHARVARD COLLEGE·Filed 1995·Granted Jul 1, 1997·7 cites·8 claims
- 1352US5369014AIn-vitro method for determining a surreptitious use of exogenous erythropoiesis stimulating agents by a normal living subjectBETH ISRAEL HOSPITAL ASSOC·Filed 1992·Granted Nov 29, 1994·21 cites·5 claims
- 1452US2002119953A1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseFiled 2001·Application pending·0 cites
- 1550US7342038B2Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferationHARVARD COLLEGE·Filed 2004·Granted Mar 11, 2008·0 cites·15 claims
- 1650US2003119784A1Method for reducing chloride secretion by intestinal epithelial cells in situ: use of triaryl methane compoundsFiled 2002·Application pending·0 cites
- 1748US6291449B1Use of 11-phenyl-dibenzazepine compounds to treat diarrhea or scoursCHILDRENS MEDICAL CENTER·Filed 1998·Granted Sep 18, 2001·3 cites·34 claims
- 1847US2003191111A1Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 2003·Application pending·0 cites
- 1945US2002128256A1Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferationFiled 2001·Application pending·0 cites
- 2042US7531573B2Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseCHILDRENS MEDICAL CENTER·Filed 2003·Granted May 12, 2009·0 cites·11 claims
- 2140US5556871AMethod for treating epithelial precancerous lesions with topical inidazolesHARVARD COLLEGE·Filed 1995·Granted Sep 17, 1996·8 cites·19 claims
- 2240US5441957AMethod for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situBETH ISRAEL HOSPITAL ASSOC INC·Filed 1993·Granted Aug 15, 1995·6 cites·7 claims
- 2338US10179115B2Methods for treating malaria using potassium channel inhibitorsCHILDRENS MEDICAL CT CORP·Filed 2016·Granted Jan 15, 2019·0 cites·17 claims
- 2436US5591763Atreatments for diseases characterized by neovascularizationHARVARD COLLEGE·Filed 1995·Granted Jan 7, 1997·1 cites·18 claims
- 2534US6992079B2Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationNUCHEM PHARMACEUTICALS INC·Filed 2001·Granted Jan 31, 2006·0 cites·22 claims
- 2634US6534497B1Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationNUCHEM PHARMACEUTICALS INC·Filed 1998·Granted Mar 18, 2003·3 cites·29 claims
- 2729US2002004519A1Method for reducing chloride secetion by intestinal epithlial cells in situFiled 1998·Application pending·0 cites
- 2827US2003134842A1Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferationFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →